https://doi.org/10.30702/Ophthalmology.2019/09.083441

Malachkova N.V.¹, Kryvetska N.V.¹, Bersanukaieva Y.V.²

¹National Pirogov Memorial Medical University, Vinnytsia, Ukraine
²Ophthalmology Clinic “Optimalˮ, Vinnytsia, Ukraine

Summary

Introduction. The article shows the results of the study of early diagnosis and treatment of acute conjunctivitis in children.

Aim. To determine the parents’ attitude to the problem of conjunctivitis in children, their awareness about the disease as well as possible consequences and complications of the inflammatory process, to identify the most “popularˮ antibacterial eye drops among the parents whose children have had conjunctivitis within the last year.

Materials and methods. Questionnaire of 150 parents of children aged from 2 months to 13 years and have had acute bacterial conjunctivitis within the last year was used. Bacteriological assessment of 38 conjunctival samples was carried out.

Results. The purulent discharge but not conjunctival hyperemia makes the parents pay their attention to the child’s ocular problem in 92.85 % cases. Only 70 % of the parents sought medical attention. In order to choose a medication for the treatment of their child, 62 % of parents consulted a pharmacist in a pharmacy, 7 % considered advertising, 17.3 % were guided by their own experience and 13.8 % used experience and advice of relatives. Self-treatment with antibacterial eye drops lasted about 10 days. The conjunctival bacteriological pre-treatment assessment was not conducted in 72 % cases.

Conclusions. Awareness of the population about inflammatory conditions of conjunctiva, their consequences and possible complications remains low, as treatment was often carried out as a self-treatment. All of the above leads to the complications of the disease and increases duration and cost of the treatment.

Keywords: bacterial conjunctivitis, children, treatment efficacy.

REFERENCES
1. Antipova YuN, Antipova LN. [Experience of Oftaqix usage in pediatric ophthalmology]. Clinicheskaya ophthalmologiya. 2009;10(4):151–2. (in Russian).
2. Bessikalo VI, Reznichenko YuG, Solovieva SP, Odinokova ZhG, Samus TYu, Pavlova OP. [Ways of improvement of recurrent inflammation of the eye in children and adolescents]. Journal of Ophthalmology. 2006;5:25–7. (in Russian).
3. Bobrova NF, Molodaya AL. [Microflora in conjunctivitis and dacryocystitis in newborns and its sensitivity to antibacterial drugs]. Journal of Ophthalmology. 2011;6:4–7. (in Russian). http://doi.org/10.31288/oftalmolzh2011648
4. Vorontsova TN, Brzheskiy VV, Mikchailova MV. Microflora of conjunctiva in children and its sensitivity and resistance to antibacterial drugs. Ophthalmologiya in Russia. 2012;9(1):83-91. (in Russian). https://doi.org/10.18008/1816-5095-2012-1-83-91
5. Dolzhich GI, Eliseeva GV. [Phloxal in the treatment of bacterial conjunctivitis in children]. Pediatric Ophthalmology: results and perspectives: Proceedings of the Scientific and Practical Conference; 2006 Nov 21–23; Moscow, Russia. Moscow; 2006. p. 311. (in Russian).
6. Maichuk YuF. [Modern therapy of conjunctivitis in children]. Pediatriya. 2007;(2):80–7. (in Russian).
7. Okolov IN, Gurchenok PA, Vokhmyakov AV. [Antibiotic resistance patterns of conjunctival coagulase-negative staphylococci isolates]. Ophthalmologicheskiye vyedomosti. 2009;2(2): 43–7. (in Russian).
8. Petrunya A, Selivanova O, Stepanenko G. [To the ground of application of thiol drugs at bacterial conjunctivitis treatment]. Archive of Ukrainian Ophthalmology. 2013;1(1):60–7. (in Russian).
9. Rykov S, Shargorodska I, Yakovets A. [Some aspects of treatment of “red eyeˮ syndrome in children and adolescents]. Ophthalmology. Eastern Europe. 2017;7(3):319–29. (in Russian).
10. Savko VV, Naritsina NI, Konovalova NV, Novik AYa. [Efficacy of the drug Artelak in rehabilitation of patients with inflammatory diseases of the anterior section of the eye]. Journal of Ophthalmology. 2008;(4):5–7. (in Russian).
11. Hemavathi, Sarmah P, Shenoy P. Profile of Microbial Isolates in Ophthalmic Infections and Antibiotic Susceptibility of the Bacterial Isolates: A Study in an Eye Care Hospital, Bangalore. J Clin Diagn Res. 2014;8(1):23–5.
12. Teweldemedhin M, Gebreyesus H, Atsbaha AH, Asgedom SW, Saravanan M. Bacterial profile of ocular infections: a systematic review. BMC Ophthalmology. 2017;17:212 https://doi.org/10.1186/s12886-017-0612-2
13. Miller D. Update on the epidemiology and antibiotic resistance of ocular infections. Middle East Afri J Ophthalmol. 2017;24(1):30–42.
14. Summaiya M, Neeta K, Sangita R. Ocular infections: rational approach to antibiotic therapy. Natl J Med Res. 2012;2(1):22–4.
15. Tesfaye T, Beyene G, Gelaw Y, Bekele S, Saravanan M. Bacterial profile and antimicrobial susceptibility pattern of external ocular infections in Jimma University specialized hospital, Southwest Ethiopia. AJIGM. 2013;1(1):13–20.
16. Wong VW, Lay TY, Chi SC, Lam DS. Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment. Cornea. 2011;30:995–1002.

Received: 13 Aug. 2018

Published: April 2019